This company listing is no longer active
This company may still be operating, however this listing is no longer active. Find out why through their latest events.
Resumen de acción ALDEI
DEINOVE SA, a biotechnology company, discovers, develops, and produces compounds from microbials for the health, nutrition, and cosmetics industries worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Competidores de Deinove SA
Historial de precios y rendimiento
| Historical stock prices | |
|---|---|
| Current Share Price | €0.026 |
| 52 Week High | €0.31 |
| 52 Week Low | €0.0062 |
| Beta | 0.78 |
| 1 Month Change | 0% |
| 3 Month Change | 10.42% |
| 1 Year Change | -91.12% |
| 3 Year Change | -96.30% |
| 5 Year Change | -99.29% |
| Change since IPO | -99.67% |
Noticias y actualizaciones recientes
Recent updates
Rentabilidad de los accionistas
| ALDEI | FR Chemicals | Mercado FR | |
|---|---|---|---|
| 7D | 0% | -0.9% | -0.03% |
| 1Y | -91.1% | 13.6% | 1.8% |
Rentabilidad vs. Industria: ALDEI underperformed the French Chemicals industry which returned 4% over the past year.
Rentabilidad vs. Mercado: ALDEI underperformed the French Market which returned 11.4% over the past year.
Volatilidad de los precios
| ALDEI volatility | |
|---|---|
| ALDEI Average Weekly Movement | n/a |
| Chemicals Industry Average Movement | 5.6% |
| Market Average Movement | 4.4% |
| 10% most volatile stocks in FR Market | 9.7% |
| 10% least volatile stocks in FR Market | 2.3% |
Precio estable de las acciones: ALDEI has not had significant price volatility in the past 3 months.
Volatilidad a lo largo del tiempo: Insufficient data to determine ALDEI's volatility change over the past year.
Acerca de la empresa
| Fundada | Empleados | CEO | Página web |
|---|---|---|---|
| 2006 | 44 | Alexis Rideau | www.deinove.com |
Resumen de fundamentos de Deinove SA
| Estadísticas fundamentales de ALDEI | |
|---|---|
| Capitalización bursátil | €843.07k |
| Beneficios(TTM) | -€7.37m |
| Ingresos (TTM) | €241.00k |
3.5x
Ratio precio-ventas (PS)-0.1x
Ratio precio-beneficio (PE)¿Está ALDEI sobrevalorada?
Ver valor justo y análisis de valoraciónBeneficios e Ingresos
| Cuenta de resultados (TTM) de ALDEI | |
|---|---|
| Ingresos | €241.00k |
| Coste de los ingresos | €3.91m |
| Beneficio bruto | -€3.67m |
| Otros gastos | €3.71m |
| Beneficios | -€7.37m |
Últimos beneficios comunicados
Jun 30, 2022
Próxima fecha de beneficios
n/a
| Beneficios por acción (BPA) | -0.23 |
| Margen bruto | -1,521.58% |
| Margen de beneficio neto | -3,058.92% |
| Ratio deuda/patrimonio | -127.0% |
¿Cómo se ha desempeñado ALDEI a largo plazo?
Ver rendimiento histórico y comparativa